Skip to main content
Journal ArticleOPEN ACCESS

Hepatocellular Carcinoma in the COVID-19 Era: Primetime for Stereotactic Body Radiotherapy and a Lesson for the Future?

  • Scorsetti M
  • Goodman K
  • Seong J
  • et al.
The Oncologist (2020) 25(8) e1249-e1250
DOI: 10.1634/theoncologist.2020-0416
9Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The COVID-19 pandemic has presented an opportunity to evaluate current practices in cancer care. This letter to the editor focuses on one example, making the case for stereotactic body radiotherapy in Hepatocellular Carcinoma.

Cite

CITATION STYLE

APA

Scorsetti, M., Goodman, K. A., Seong, J., Loi, M., Huguet, F., & Dawson, L. A. (2020). Hepatocellular Carcinoma in the COVID-19 Era: Primetime for Stereotactic Body Radiotherapy and a Lesson for the Future? The Oncologist, 25(8), e1249–e1250. https://doi.org/10.1634/theoncologist.2020-0416

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free